The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Nanoparticles for Brain Drug Delivery
Open accessAbstract
The central nervous system, one of the most delicate microenvironments of the body, is protected by the blood-brain barrier (BBB) regulating its homeostasis. BBB is a highly complex structure that tightly regulates the movement of ions of a limited number of small molecules and of an even more restricted number of macromolecules from the blood to the brain, protecting it from injuries and diseases. However, the BBB also significantly precludes the delivery of drugs to the brain, thus, preventing the therapy of a number of neurological disorders. As a consequence, several strategies are currently being sought after to enhance the delivery of drugs across the BBB. Within this review, the recently born strategy of brain drug delivery based on the use of nanoparticles, multifunctional drug delivery systems with size in the order of one-billionth of meters, is described. The review also includes a brief description of the structural and physiological features of the barrier and of the most utilized nanoparticles for medical use. Finally, the potential neurotoxicity of nanoparticles is discussed, and future technological approaches are described. The strong efforts to allow the translation from preclinical to concrete clinical applications are worth the economic investments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Diffusion in Brain Extracellular Space
Syková, E., & Nicholson, C. (2008) · Physiological Reviews · doi:10.1152/physrev.00027.2007 · Cited by 1,481
Drug Development and Industrial Pharmacy
Rhodes, C. T. (1995) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049509070870 · Cited by 1,263
Translocation of Inhaled Ultrafine Manganese Oxide Particles to the CentralNervous System
Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., Finkelstein, J., et al. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9030 · Cited by 1,180
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Inflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 795
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yang, Y., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.608257 · Cited by 789
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Hillyer, J. F., & Albrecht, R. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1143 · Cited by 706
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Thorne, R. G., & Nicholson, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509425103 · Cited by 641
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
The transferrin receptor: role in health and disease
Ponka, P., & Lok, C. N. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00070-9 · Cited by 595
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · cited 1×
“Finally, also Angiopep-2, a ligand of LRP, possesses a high brain penetration capability in both in vitro model of the BBB and in situ brain perfusion in mice [100].”
BackgroundBlood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., & Eisdorfer, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00207-1 · Cited by 537
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Iron trafficking inside the brain
Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 420
Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z., Qian, Y., Sun, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.025 · Cited by 408
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399
Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model
Kannan, S., Dai, H., Navath, R. S., Balakrishnan, B., Jyoti, A., Janisse, J., Romero, R., & Kannan, R. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003162 · Cited by 399
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
One at a time, live tracking of NGF axonal transport using quantum dots
Cui, B., Wu, C., Chen, L., Ramirez, A., Bearer, E. L., Li, W.-P., Mobley, W. C., & Chu, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706192104 · Cited by 364
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
Petty, M. A., & Lo, E. H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00128-4 · Cited by 360
Gartner, S. (2000) · Science · doi:10.1126/science.287.5453.602 · Cited by 354
de Boer, A. G., & Gaillard, P. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 348
Ke, W., Shao, K., Huang, R., Han, L., Liu, Y., Li, J., Kuang, Y., Ye, L., Lou, J., & Jiang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.049 · Cited by 337
Kumagai, A. K., Eisenberg, J. B., & Pardridge, W. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48160-4 · Cited by 325
Schleh, C., Semmler-Behnke, M., Lipka, J., Wenk, A., Hirn, S., Schäffler, M., Schmid, G., Simon, U., & Kreyling, W. G. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.552811 · Cited by 325
Oncotic pressures opposing filtration across non‐fenestrated rat microvessels
Adamson, R. H., Lenz, J. F., Zhang, X., Adamson, G. N., Weinbaum, S., & Curry, F. E. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.058255 · Cited by 323
Microglial Response to Gold Nanoparticles
Hutter, E., Boridy, S., Labrecque, S., Lalancette-Hébert, M., Kriz, J., Winnik, F. M., & Maysinger, D. (2010) · ACS Nano · doi:10.1021/nn901869f · Cited by 320
Pardridge, W. M., Kang, Y.-S., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 315
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 311
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Sadekar, S., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.010 · Cited by 311
Li, Y., He, H., Jia, X., Lu, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310
Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
Wolak, D. J., & Thorne, R. G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300495e · Cited by 299
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Nanoparticles and Neurotoxicity
Win-Shwe, T.-T., & Fujimaki, H. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12096267 · Cited by 296
Treat, L. H., McDannold, N., Zhang, Y., Vykhodtseva, N., & Hynynen, K. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.04.015 · Cited by 296
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Tuan Giam Chuang, V., Kragh-Hansen, U., & Otagiri, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1015396825274 · Cited by 295
Kabanov, A. V., Batrakova, E. V., Melik-Nubarov, N. S., Fedoseev, N. A., Dorodnich, T. Y., Alakhov, V. Y., Chekhonin, V. P., Nazarova, I. R., & Kabanov, V. A. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90199-2 · Cited by 295
Mediators of Blood-Brain Barrier Dysfunction and Formation of Vasogenic Brain Edema
Wahl, M., Unterberg, A., Baethmann, A., & Schilling, L. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.109 · Cited by 294
Lee, H. J., Engelhardt, B., Lesley, J., Bickel, U., & Pardridge, W. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35388-1 · Cited by 287
Neurotoxicity of Silica Nanoparticles: Brain Localization and Dopaminergic Neurons Damage Pathways
Wu, J., Wang, C., Sun, J., & Xue, Y. (2011) · ACS Nano · doi:10.1021/nn103530b · Cited by 286
Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier
Chang, J., Jallouli, Y., Kroubi, M., Yuan, X.-B., Feng, W., Kang, C.-S., Pu, P.-Y., & Betbeder, D. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.035 · Cited by 278
Sarin, H., Kanevsky, A. S., Wu, H., Brimacombe, K. R., Fung, S. H., Sousa, A. A., Auh, S., Wilson, C. M., Sharma, K., Aronova, M. A., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-80 · Cited by 274
Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
Prades, R., Guerrero, S., Araya, E., Molina, C., Salas, E., Zurita, E., Selva, J., Egea, G., López-Iglesias, C., Teixidó, M., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.063 · Cited by 270
Koffie, R. M., Farrar, C. T., Saidi, L.-J., William, C. M., Hyman, B. T., & Spires-Jones, T. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111405108 · Cited by 260
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier
Barbu, E., Molnàr, É., Tsibouklis, J., & Górecki, D. C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939143 · Cited by 229
Kotzé, A. F., Lueßen, H. L., de Leeuw, B. J., de Boer, (. G., Coos Verhoef, J., & Junginger, H. E. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00154-5 · Cited by 226
In vivo MRI of brain inflammation in human ischaemic stroke
Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H.-P., Modder, U., & Jander, S. (2004) · Brain · doi:10.1093/brain/awh191 · Cited by 226
Enzmann, G., Mysiorek, C., Gorina, R., Cheng, Y.-J., Ghavampour, S., Hannocks, M.-J., Prinz, V., Dirnagl, U., Endres, M., Prinz, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1076-3 · Cited by 225
Kim, J.-Y., Choi, W. I., Kim, Y. H., & Tae, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.047 · Cited by 219
Neuwelt, E. A., Várallyay, P., Bagó, A. G., Muldoon, L. L., Nesbit, G., & Nixon, R. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00557.x · Cited by 219
Solid lipid based nanocarriers: An overview / Nanonosači na bazi čvrstih lipida: Pregled
Pardeshi, C., Rajput, P., Belgamwar, V., Tekade, A., Patil, G., Chaudhary, K., & Sonje, A. (2012) · Acta Pharmaceutica · doi:10.2478/v10007-012-0040-z · Cited by 214
Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213
Georgieva, J. V., Kalicharan, D., Couraud, P.-O., Romero, I. A., Weksler, B., Hoekstra, D., & Zuhorn, I. S. (2011) · Molecular Therapy · doi:10.1038/mt.2010.236 · Cited by 209
Santaguida, S., Janigro, D., Hossain, M., Oby, E., Rapp, E., & Cucullo, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.027 · Cited by 209
Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides
Laskowitz, D. T., Thekdi, A. D., Thekdi, S. D., Han, S. K. D., Myers, J. K., Pizzo, S. V., & Bennett, E. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7541 · Cited by 206
Drug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers
M. Rabanel, J., Aoun, V., Elkin, I., Mokhtar, M., & Hildgen, P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784702 · Cited by 205
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
Dousset, V., Delalande, C., Ballarino, L., Quesson, B., Seilhan, D., Coussemacq, M., Thiaudi�re, E., Brochet, B., Canioni, P., & Caill�, J.-M. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199902)41:2<329::aid-mrm17>3.0.co;2-z · Cited by 204
Sucrose and inulin space measurements of cerebral cortex in four mammalian species
Levin, V., Fenstermacher, J., & Patlak, C. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.5.1528 · Cited by 200
Toxico-/biokinetics of nanomaterials
Landsiedel, R., Fabian, E., Ma-Hock, L., Wohlleben, W., Wiench, K., Oesch, F., & van Ravenzwaay, B. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0858-7 · Cited by 191
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
Mishra, V., Mahor, S., Rawat, A., Gupta, P. N., Dubey, P., Khatri, K., & Vyas, S. P. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600612953 · Cited by 191
Lin, X.-N., Tian, Wei, Feng, Huang, Wang, Ren, & Diao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16570 · Cited by 189
Karatas, H., Aktas, Y., Gursoy-Ozdemir, Y., Bodur, E., Yemisci, M., Caban, S., Vural, A., Pinarbasli, O., Capan, Y., Fernandez-Megia, E., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4246-09.2009 · Cited by 187
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Bellavance, M.-A., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 184
Dousset, V., Brochet, B., Deloire, M. S. A., Lagoarde, L., Barroso, B., Caillé, J. M., & Petry, K. G. (2006) · PubMed · Cited by 183
Albertazzi, L., Gherardini, L., Brondi, M., Sulis Sato, S., Bifone, A., Pizzorusso, T., Ratto, G. M., & Bardi, G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300391v · Cited by 181
Re, F., Cambianica, I., Zona, C., Sesana, S., Gregori, M., Rigolio, R., La Ferla, B., Nicotra, F., Forloni, G., Cagnotto, A., et al. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.004 · Cited by 181
Self-citationWang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.015 · Cited by 173
Self-citationBroadwell, R. D. (1989) · Acta Neuropathologica · doi:10.1007/bf00294368 · Cited by 171
Interactions of Engineered Nanoparticles with Organs Protected by Internal Biological Barriers
Pietroiusti, A., Campagnolo, L., & Fadeel, B. (2013) · Small · doi:10.1002/smll.201201463 · Cited by 171
Kim, H. R., Andrieux, K., Gil, S., Taverna, M., Chacun, H., Desmaële, D., Taran, F., Georgin, D., & Couvreur, P. (2007) · Biomacromolecules · doi:10.1021/bm060711a · Cited by 170
Zhang, Y., & Pardridge, W. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03108-5 · Cited by 167
MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE
Rausch, M., Hiestand, P., Baumann, D., Cannet, C., & Rudin, M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10541 · Cited by 162
Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 160
Dutta, T., Agashe, H. B., Garg, M., Balasubramanium, P., Kabra, M., & Jain, N. K. (2007) · Journal of drug targeting · doi:10.1080/10611860600965914 · Cited by 157
Peptides crossing the blood–brain barrier: some unusual observations
Kastin, A. J., Pan, W., Maness, L. M., & Banks, W. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01961-7 · Cited by 156
Polymeric micelles anchored with TAT for delivery of antibiotics across the blood–brain barrier
Liu, L., Venkatraman, S. S., Yang, Y. Y., Guo, K., Lu, J., He, B., Moochhala, S., & Kan, L. (2008) · Biopolymers · doi:10.1002/bip.20998 · Cited by 155
Buse, J. D., & El‐Aneed, A. (2010) · Nanomedicine · doi:10.2217/nnm.10.107 · Cited by 155
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
In Vivo Specific Delivery of c-Met siRNA to Glioblastoma Using Cationic Solid Lipid Nanoparticles
Jin, J., Bae, K. H., Yang, H., Lee, S. J., Kim, H., Kim, Y., Joo, K. M., Seo, S. W., Park, T. G., & Nam, D. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200406n · Cited by 149
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage
Rausch, M., Sauter, A., Froehlich, J. M., Neubacher, U., Radue, E. W., & Rudin, M. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1290 · Cited by 149
Madan, J., Pandey, R. S., Jain, V., Katare, O. P., Chandra, R., & Katyal, A. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.10.003 · Cited by 146
Dousset, V., Ballarino, L., Delalande, C., Coussemacq, M., Canioni, P., Petry, K. G., & Caillé, J. M. (1999) · PubMed · Cited by 145
Md, S., Ali, M., Baboota, S., Sahni, J. K., Bhatnagar, A., & Ali, J. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.758130 · Cited by 138
Lai, F., Fadda, A. M., & Sinico, C. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.766714 · Cited by 132
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes
Afergan, E., Epstein-Barash, H., Dahan, R., Koroukhov, N., Rohekar, K., Danenberg, H. D., & Golomb, G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.017 · Cited by 130
Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art
Petkar, K. C., Chavhan, S. S., Agatonović-Kuštrin, S., & Sawant, K. K. (2011) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v28.i2.10 · Cited by 130
Inflammatory Response After Ischemic Stroke
Nighoghossian, N., Wiart, M., Cakmak, S., Berthezène, Y., Derex, L., Cho, T., Nemoz, C., Chapuis, F. R., Tisserand, G. L., Pialat, J., et al. (2006) · Stroke · doi:10.1161/01.str.0000254548.30258.f2 · Cited by 130
Functional Protein Delivery into Neurons Using Polymeric Nanoparticles
Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 129
Sousa, F., Mandal, S., Garrovo, C., Astolfo, A., Bonifacio, A., Latawiec, D., Menk, R. H., Arfelli, F., Hüwel, S., Legname, G., et al. (2010) · Nanoscale · doi:10.1039/c0nr00345j · Cited by 126
Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice
Ze, Y., Zheng, L., Zhao, X., Gui, S., Sang, X., Su, J., Guan, N., Zhu, L., Sheng, L., Hu, R., et al. (2013) · Chemosphere · doi:10.1016/j.chemosphere.2013.01.094 · Cited by 125
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122
Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Muro, S., Koval, M. H., & Muzykantov, V. R. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043385736 · Cited by 122
MR imaging of phagocytosis in experimental gliomas.
Zimmer, C., Weissleder, R., Poss, K., Bogdanova, A., Wright, S. C., & Enochs, W. S. (1995) · Radiology · doi:10.1148/radiology.197.2.7480707 · Cited by 121
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 120
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
Kanwar, J. R., Sriramoju, & Kanwar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30919 · Cited by 119
Brock, J. H. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-018 · Cited by 119
Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model
Pandey, R., & Khuller, G. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl128 · Cited by 118
Candela, P., Gosselet, F., Miller, F., Buee-Scherrer, V., Torpier, G., Cecchelli, R., & Fenart, L. (2008) · Endothelium · doi:10.1080/10623320802487759 · Cited by 117
Sauer, I., Dunay, I. R., Weisgraber, K. H., Bienert, M., & Dathe, M. (2005) · Biochemistry · doi:10.1021/bi048080x · Cited by 117
Singh, S. P., Rahman, M. F., Murty, U. S. N., Mahboob, M., & Grover, P. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.10.016 · Cited by 117
Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
Xu, Q., Wang, C., & Pack, D. W. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920469 · Cited by 115
Šekeljić, V., Bataveljić, D., Stamenković, S., Ułamek, M., Jabłoński, M., Radenović, L., Pluta, R. M., & Anđjus, P. R. (2011) · Brain Structure and Function · doi:10.1007/s00429-011-0336-7 · Cited by 114
Targeting liposomes with protein drugs to the blood–brain barrier in vitro
Visser, C. C., Stevanović, S., Voorwinden, L. H., van Bloois, L., Gaillard, P. J., Danhof, M., Crommelin, D. J. A., & de Boer, A. G. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.008 · Cited by 114
The Blood–Brain Barrier in Alzheimer's Disease
Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 111
Rausch, M., HIESTAND, P. C., Foster, C. A., Kindler, D., Cannet, C., & Rudin, M. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20057 · Cited by 109
Therapeutic and Diagnostic Applications of Nanoparticles
Youns, M., Hoheisel, J. D., & Efferth, T. (2011) · Current Drug Targets · doi:10.2174/138945011794815257 · Cited by 107
Lindqvist, A., Rip, J., Gaillard, P. J., Björkman, S. E., & Hammarlund‐Udenaes, M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300272a · Cited by 106
Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier
Minn, A., Leclerc, S., Heydel, J., Minn, A.-L., Denizot, C., Cattarelli, M., Netter, P., & Grădinaru, D. (2002) · Journal of drug targeting · doi:10.1080/713714452 · Cited by 106
Imaging Inflammation in Acute Brain Ischemia
Jander, S., Schroeter, M., & Saleh, A. (2007) · Stroke · doi:10.1161/01.str.0000250048.42916.ad · Cited by 101
Papisov, M. I., Belov, V. V., & Gannon, K. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300474m · Cited by 97 · cited 1×
“The most extended area where, presumably, a more extensive passage of NPs could be possible is occupied by the leptomeningeal space, which is the space occupied by Cerebrospinal fluid (CSF), including all spaces continuous with the subarachnoid space, such as perivascular spaces and ventricles [182].”
BackgroundSchroeter, M., Saleh, A., Wiedermann, D., Hoehn, M., & Jander, S. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20142 · Cited by 93
Liu, X., An, C., Jin, P., Liu, X., & Wang, L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.017 · Cited by 93
Re, F., Salvati, Sesana, Cambianica, Sancini, G., Masserini, & Gregori (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s42783 · Cited by 93
Bolton, S. J., & Perry, V. H. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6927 · Cited by 91
In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO
Rausch, M., Baumann, D., Neubacher, U., et al. (2002) · NMR in Biomedicine · doi:10.1002/nbm.770 · Cited by 90
Uses of Nanoparticles for Central Nervous System Imaging and Therapy
Provenzale, J. M., & Silva, G. A. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1590 · Cited by 89
Datta, G., Chaddha, M., Garber, D. W., Chung, B. H., Tytler, E. M., Dashti, N., Bradley, W. A., Gianturco, S. H., & Anantharamaiah, G. M. (1999) · Biochemistry · doi:10.1021/bi991209w · Cited by 88
Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons
da Cruz, M. T. G., Simões, S., & de Lima, M. C. P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.013 · Cited by 88
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.007 · Cited by 87
Self-citationTreatment of cerebral ischemia‐reperfusion injury with PEGylated liposomes encapsulating FK506
Ishii, T., Asai, T., Oyama, D., Agato, Y., Yasuda, N., Fukuta, T., Shimizu, K., Minamino, T., & Oku, N. (2012) · The FASEB Journal · doi:10.1096/fj.12-221325 · Cited by 85
Brochet, B., Deloire, M. S. A., Touil, T., Anne, O., Caillé, J. M., Dousset, V., & Petry, K. G. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.03.028 · Cited by 84
Zhang, X., Chen, G., Wen, L., Yang, F., Shao, A.-L., Li, X., Long, W., & Mu, L. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.01.007 · Cited by 80
Altering Iron Oxide Nanoparticle Surface Properties Induce Cortical Neuron Cytotoxicity
Rivet, C. J., Yuan, Y., Borca‐Tasciuc, D., & Gilbert, R. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200369s · Cited by 78
Manninger, S., Muldoon, L. L., Nesbit, G. M., Murillo, T. P., Jacobs, P. M., & Neuwelt, E. A. (2005) · PubMed · Cited by 77
Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells
Kania, K., Wijesuriya, H. C., Hladky, S. B., & Barrand, M. A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.044 · Cited by 70
Nagpal, K., Singh, S. K., & Mishra, D. N. (2012) · Drug Delivery · doi:10.3109/10717544.2012.738437 · Cited by 68
Wei, F., Tian, T., Wei, F., Wang, T., Wang, P., Lin, X., Wang, J., Wang, D., & Ren, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26541 · Cited by 68
Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat
Deng, X., Wang, X., & Andersson, R. E. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.78.6.2052 · Cited by 67
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 66
Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain
Parikh, T., Bommana, M. M., & Squillante, E. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.11.001 · Cited by 66
Choonara, Y. E., Pillay, V., Ndesendo, V. M. K., du Toit, L. C., Kumar, P., Khan, R., Murphy, C. S., & Jarvis, D.-L. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.025 · Cited by 62
Coating of cationized protein on engineered nanoparticles results in enhanced immune responses
Cui, Z., & Mumper, R. J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00079-0 · Cited by 62
Chen, H., Spagnoli, F., Burris, M. B., Rolland, W. B., Fajilan, A., Dou, H., Tang, J., & Zhang, J. H. (2011) · Stroke · doi:10.1161/strokeaha.111.637090 · Cited by 57
Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles
Dakwar, G. R., Hammad, I. A., Popov, M., Linder, C., Grinberg, S., Heldman, E., & Stepensky, D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.042 · Cited by 54
Hülsermann, U., Hoffmann, M. M., Massing, U., & Fricker, G. (2009) · Journal of drug targeting · doi:10.1080/10611860903105986 · Cited by 51
Datta, G., Garber, D. W., Chung, B. H., Chaddha, M., Dashti, N., Bradley, W. A., Gianturco, S. H., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31620-5 · Cited by 50
Dhanikula, R. S., Hammady, T. M., & Hildgen, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21669 · Cited by 50
Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor
Dyer, C. A., Cistola, D. P., Parry, G. C., & Curtiss, L. K. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39756-x · Cited by 50
Kleinschnitz, C., Schütz, A., Nolte, I. S., Horn, T., Frank, M., Solymosi, L., Stoll, G., & Bendszus, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600151 · Cited by 49
Bergen, J. M., & Pun, S. H. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1137 · Cited by 49
Zhao, M., Chang, J. K., Fu, X., Liang, C., Liang, S., Yan, R., & Li, A.-M. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2011.651726 · Cited by 48
Chapter 20 Cytokines and blood-brain barrier permeability
Boer, A. G. D., & Breimer, D. D. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)62045-2 · Cited by 46
Nanostructures for Drug Delivery to the Brain
Martín‐Banderas, L., Holgado, M. A., Venero, J. L., et al. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798184262 · Cited by 45
Lou, J.-N., Chofflon, M., Juillard, C., Donati, Y. R. A., Mili, N., Siegrist, C., & Grau, G. E. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00010 · Cited by 44
Bao, H., Jin, X., Li, L., Lv, F., & Liu, T. (2012) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-012-4658-7 · Cited by 42
Lalani, J., Raichandani, Y., Mathur, R., Lalan, M. S., Chutani, K., Mishra, A. K., & Misra, A. R. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1462 · Cited by 41
Transport of a Caspase Inhibitor Across the Blood–Brain Barrier by Chitosan Nanoparticles
Yemişçi, M., Özdemir, Y., Caban-Toktas, S., Bodur, E., Çapan, Y., & Dalkara, T. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00013-6 · Cited by 36
Engberink, R. D. O., Blezer, E. L. A., Dijkstra, C. D., van der Pol, S. M. A., van der Toorn, A., & de Vries, H. E. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1536 · Cited by 35
Baeten, K., Hendriks, J. J. A., Hellings, N., Theunissen, E., Vanderlocht, J., Ryck, L. D., Gelan, J., Stinissen, P., & Adriaensens, P. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.008 · Cited by 34
Orthmann, A., Zeisig, R., Süss, R., Lorenz, D., Lemm, M., & Fichtner, I. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0723-7 · Cited by 34
Trojan monocytes for improved drug delivery to the brain
Park, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.009 · Cited by 31
Mims, M. P., Darnule, A. T., Tovar, R. W., Pownall, H. J., Sparrow, D. A., Sparrow, J. T., Via, D. P., & Smith, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32027-6 · Cited by 30
Wang, X.-S., Ciraolo, G. M., Morris, R., & Gruenstein, E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00877-9 · Cited by 26
Leupold, E., Nikolenko, H., & Dathe, M. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.025 · Cited by 25
Xu, K., Wang, H., Liu, L., Xu, W., Sheng, J., Fan, W., Yang, Y. Y., & Li, L. (2011) · Chemotherapy · doi:10.1159/000330855 · Cited by 25
Holmes, D. I. R. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70313-7 · Cited by 20
Lipid-DNA and lipid-polyelectrolyte mesophases: structure and exchange kinetics.
Artzner, F., Zantl, R., & Rädler, J. O. (2000) · PubMed · Cited by 19
Xu, P., Li, J., Chen, B., Wang, X., Cai, X., Jiang, H., Wang, C., & Zhang, H. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1402 · Cited by 13
Andersen, A. J., Hashemi, S. H., Galimberti, G. A., Re, F., Masserini, M., & Moghimi, S. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.08.252 · Cited by 6
Self-citation
Cited by
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
“Very often it also accelerates blood clearance of theNPs through the reticuloendothelial system localized mostly in the spleen and liver [39,68], which may decrease the NP dose available for accumulation in the brain aswell as induce inflammation.”
BackgroundTherapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
“However, some studies suggested that nanoparticles may not be internalized by cells and the enhanced drug uptake in the brain is non-specific [29, 42, 43].”
BackgroundOvercoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Metadata
- Authors
- Masserini, M.
- Venue
- ISRN Biochemistry
- Publisher
- Hindawi Limited
- Published
- 2013-05-21
- Volume
- 2013
- Pages
- 1-18
- ISSN
- 2090-7729 (ISSN-L)
- OpenAlex
- W2011005493
- Cited by
- 489
- References
- 182
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.